---
created: 2025-04-13
updated: 2025-04-13T10:53
id: EY~)Hs~p,U
specialty: pharmaco
specialty_id: 360
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::01-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites::pyrimidine-synthesis-inhibitors::methotrexate
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::02-pathology::28-polymyositis/dermatomyositis::dermatomyositis
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::02-pathology::28-polymyositis/dermatomyositis::polymyositis
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::01-antimetabolites::01-methotrexate,-leucovorin,-5-fluorouracil,-hydroxyurea::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::900-999::940
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Treatment of Polymyositis / Dermatomyositis involves **corticosteroids** followed by long-term **methotrexate** therapy

---

# Answer
